Heraeus buys Biomain from its management shareholders

We advised Heraeus

HSCie Customer

Heraeus, Hanau, Germany
Heraeus, the precious metals and technology group headquartered in Hanau, Germany, is a global, private company with over 155 years of tradition. Its businesses include precious metals, sensors, biomaterials and medical products, dental products, quartz glass, and specialty light sources. With product revenues of € 4.1 billion and precious metal trading revenues of € 17.9 billion, as well as more than 12,600 employees in over 120 subsidiaries worldwide, Heraeus holds a leading position in its global markets.

Transaction Object

Biomain AB, Helsingborg, Sweden
Biomain AB is the Scandinavian market leader in the field of customized CAD/CAM-based implant borne prosthetics. The company was founded in 2002 and manufactures highly precise CAD/CAM frameworks, suprastructures and prosthetic components in its production and development center in Helsingborg, Sweden. Products include the I-Bridge2® implant bridge with its patented and versatile angled screw design made of titanium, cobalt chromium or zirconia.


Management Shareholders


The Business Group Heraeus Dental of the precious metals and technology group Heraeus has acquired all shares of Biomain AB. With this acquisition Heraeus strengthens its presence in the Northern European Dental CAD/CAM market and extends its patent and product portfolio in digital implant prosthetics.

Year: 2012
Transaction value: Not published
Industry: Healthcare
Business field: Mergers & Acquisitions

Further Transactions